… on the ability to protect the nigrostriatal dopamine system in a pre-clinical model of Parkinsonism (using the … and were found to have different effects on the dopamine system in a pre-clinical model of Parkinson’s disease.  …

… were used to deliver alpha-synuclein to the nigrostriatal system. In the present study, we propose to utilize … in the aged pre-clincial model nigrostriatal system and to directly compare findings to results from …

… high molecular weight drug delivery to the central nervous system due to the presence of the blood-brain barrier. The … the use of these grafts to allow direct central nervous system access for high molecular weight fluorescent markers …

… models of the disease we will have an excellent system in which we can study how cellular PD changes develop. Using this model system, we hope to be able to identify the mechanisms that …

… and fewer and fewer dopamine terminals survive, another system kicks in: the seratonin neurons. The serotonin … dopamine in a physiological manner. The seratonin system is known to be affected in PD, but the extent of … innervation in the synthesis and release of dopamine from systematically administered levodopa and in the development …

… of a good thing may be harmful. The question of how the systemic inflammation leads to brain inflammation remains to … for years.” Watch a webinar for more on the immune system’s role in Parkinson’s disease. Maggie Kuhl Vice …